temporal arteritis: Giant cell arteritis (GCA) is a large vessel vasculitis predominantly involving the arteries originating from the aortic arch and especially the extracranial branches of the carotid arteries.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1769 |
4. Check minimum number of eventsNone |
1769 |
5. Include endpoints |
1769 |
6. Filter based on genotype QC (FinnGen only) |
1601 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Giant cell arteritis
based on the number of shared cases.
Similar with more cases:
- Other necrotizing vasculopathies
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9069 | 6071 | 2933 |
| Only index persons | 7652 | 5164 | 2488 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.14 | 0.17 | 0.08 |
| Only index persons | 0.16 | 0.19 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 72.33 | 72.72 | 71.45 |
| Only index persons | 71.52 | 71.93 | 70.66 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1601 | 985 | 616 |
| Unadjusted period prevalence (%) | 0.32 | 0.35 | 0.28 |
| Median age at first event (years) | 70.43 | 70.01 | 71.11 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1642
- Matched controls
- 16420
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
4503599627370496.0
307.7
1420
5
H02AB06
ATC
prednisolone; systemic
18.3
307.7
1501
6048
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
8.9
307.7
578
943
L04AX03
ATC
methotrexate; systemic
10.6
307.7
560
764
M31.6
ICD-10 Finland
Other giant cell arteritis
2976.1
307.7
411
*
M35.3
ICD-10 Finland
Polymyalgia rheumatica
59.7
307.7
610
161
PAW37
NOMESCO Finland
Biopsy of temporal artery
1148.1
307.7
592
8
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.1
253.0
1211
5188
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
15.0
252.6
236
182
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
9.1
246.2
340
460
M05BA04
ATC
alendronic acid; oral
5.9
223.4
518
1195
R51.80
ICD-10 Finland
Headache
4.8
169.3
499
1379
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
5.4
142.9
322
704
I77.6
ICD-10 Finland
Arteritis, unspecified
231.1
125.7
128
6
L88
ICPC
Rheumatoid/seropositive arthritis
7.1
116.7
188
295
R50.9
ICD-10 Finland
Fever, unspecified
3.5
100.1
439
1549
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
99.0
94
*
A02BC02
ATC
pantoprazole; systemic
4.2
95.0
1421
9942
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
82.4
1116
7068
L04AX01
ATC
azathioprine; systemic
6.5
81.5
139
230
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
8.3
79.5
107
136
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
35.3
75.9
48
14
H02AB07
ATC
prednisone; oral
3.0
69.1
371
1446
L04AC07
ATC
tocilizumab; parenteral
95.5
66.5
73
8
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.9
61.9
199
560
TPX00
NOMESCO Finland
Biopsy of artery or vein
155.6
57.3
60
*
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
17.3
56.7
47
28
N01
ICPC
Headache
3.3
56.4
243
827
A10AC01
ATC
insulin (human); parenteral
3.4
55.0
219
709
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
54.3
333
1379
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.5
53.8
108
208
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
10.0
50.3
58
60
M13.9
ICD-10 Finland
Arthritis, unspecified
3.5
49.2
187
586
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.4
46.5
421
2085
G44.2
ICD-10 Finland
Tension-type headache
2.7
46.4
296
1244
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
460.1
45.5
45
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.1
44.5
128
331
L04AA13
ATC
[U] leflunomide
5.7
44.1
84
154
H53.1
ICD-10 Finland
Subjective visual disturbances
3.2
43.4
188
638
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
428.3
42.4
42
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
41.9
315
1428
AA1AD
NOMESCO Finland
CT of head and brain
2.0
40.1
682
4276
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
5.4
39.0
79
153
P01BA02
ATC
hydroxychloroquine; oral
3.0
38.4
182
649
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
37.7
628
3888
M31.3
ICD-10 Finland
Wegener granulomatosis
375.6
37.2
37
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
36.6
726
4759
M05BA07
ATC
risedronic acid; oral
3.6
35.0
123
365
H57.1
ICD-10 Finland
Ocular pain
4.1
34.9
100
257
ZX120
NOMESCO Finland
Intravenous
2.6
34.6
224
940
A01
ICPC
Pain general/multiple sites
2.4
34.3
259
1169
M05BX04
ATC
denosumab; parenteral
2.7
33.3
204
833
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.1
31.0
135
457
J01DB01
ATC
cefalexin; oral
2.2
31.0
1373
11465
L01BA01
ATC
methotrexate; systemic
3.8
31.0
97
266
M79.6
ICD-10 Finland
Pain in limb
1.8
29.7
801
5667
M25.5
ICD-10 Finland
Pain in joint
1.9
29.7
560
3553
H04.10
ICD-10 Finland
Dry eye syndrome
2.3
29.6
250
1181
M35.5
ICD-10 Finland
Multifocal fibrosclerosis
+∞
29.3
28
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
27.8
556
3578
4465A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Giant cell arteritis
+∞
27.2
26
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
26.7
237
1140
H34.1
ICD-10 Finland
Central retinal artery occlusion
8.7
26.7
34
40
R52.9
ICD-10 Finland
Pain, unspecified
2.3
26.7
219
1020
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
26.3
444
2701
A03
ICPC
Fever
2.2
25.9
261
1322
H53.9
ICD-10 Finland
Visual disturbance, unspecified
3.4
25.4
96
298
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
25.3
372
2157
UJF32
NOMESCO Finland
Coloscopy
1.8
25.1
530
3446
R06.0
ICD-10 Finland
Dyspnoea
1.8
24.9
558
3688
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
24.7
848
6308
R51
ICD-10 Finland
Headache
3.1
24.5
105
352
R51.81
ICD-10 Finland
Facial pain NOS
4.0
24.4
70
180
JN4AD
NOMESCO Finland
Body CT examination
2.1
24.1
265
1385
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.4
24.0
185
837
M79.1
ICD-10 Finland
Myalgia
2.1
24.0
272
1438
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
23.9
370
2178
L95
ICPC
Osteoporosis
2.7
23.7
130
499
N02BE01
ATC
paracetamol; systemic, rectal
2.6
23.6
1517
13559
L04AK01
ATC
leflunomide; oral
9.5
23.6
28
30
R53
ICD-10 Finland
Malaise and fatigue
1.8
23.4
482
3099
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
23.2
717
5155
A02BC05
ATC
esomeprazole; systemic
1.7
23.0
720
5190
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
22.9
218
1077
N02AX02
ATC
tramadol; systemic, rectal
1.7
22.8
771
5669
S18
ICPC
Laceration/cut
1.7
22.4
865
6575
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
22.2
561
3811
N03AX16
ATC
[U] pregabalin
1.8
22.0
430
2712
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.1
21.9
227
1157
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
21.8
414
2590
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
21.5
631
4450
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
21.4
808
6078
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.3
21.2
80
248
J01FF01
ATC
clindamycin; systemic
1.7
21.2
470
3072
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
21.1
187
896
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
20.9
297
1693
A10AB05
ATC
insulin aspart; parenteral
2.3
20.6
161
731
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.8
20.4
362
2212
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
20.4
261
1436
A04
ICPC
Weakness/tiredness general
1.9
20.2
323
1912
N03AX12
ATC
[U] gabapentin; oral
1.9
20.1
308
1799
L04AA06
ATC
mycophenolic acid; systemic
5.4
20.0
39
73
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
20.0
345
2090
R02
ICPC
Shortness of breath/dyspnoea
1.9
19.8
289
1660
XCK00
NOMESCO Finland
Perimetry
2.4
19.8
149
666
H53.2
ICD-10 Finland
Diplopia
3.1
19.5
83
277
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
19.5
587
4143
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.3
19.3
163
765
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.6
19.3
113
449
J01MA02
ATC
ciprofloxacin; systemic
1.6
18.8
694
5136
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
18.8
18
*
M31.4
ICD-10 Finland
Aortic arch syndrome [Takayasu]
+∞
18.8
18
*
C07AB07
ATC
bisoprolol; oral
1.6
18.7
964
7718
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
101.2
18.6
20
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
18.5
152
705
J01MA14
ATC
moxifloxacin; systemic
2.1
18.2
179
892
R05
ICD-10 Finland
Cough
1.7
18.1
380
2430
M03BX02
ATC
tizanidine; oral
1.6
18.1
923
7349
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
18.0
757
5759
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
18.0
239
1328
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.3
18.0
143
654
5BA08, ,
NOMESCO Finland
7.7
17.8
25
33
J01AA02
ATC
doxycycline; systemic
1.7
17.8
1278
11038
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
17.6
184
938
R03AC02
ATC
salbutamol; inhalant
1.6
17.5
865
6815
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
17.5
124
539
H15.1
ICD-10 Finland
Episcleritis
5.6
17.5
33
60
A02BC01
ATC
omeprazole; systemic
1.6
17.4
498
3449
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.4
17.3
124
541
H25.1
ICD-10 Finland
Senile nuclear cataract
1.6
17.3
659
4886
L17
ICPC
Foot/toe symptom/complaint
1.6
17.3
547
3882
JN6JR
NOMESCO Finland
Extensive PET-CT of whole body metabolism (crown to foot)
42.5
17.3
21
5
L28
ICPC
Limited function/disability (L)
1.7
17.3
425
2832
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
17.0
328
2043
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.0
17.0
78
272
C03CA01
ATC
furosemide; systemic
1.6
16.9
677
5070
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
4.3
16.9
43
101
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.1
16.9
166
827
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
16.9
206
1111
M05BA06
ATC
ibandronic acid; systemic
3.2
16.9
68
220
J01CA04
ATC
amoxicillin; systemic
1.7
16.8
1265
10951
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
16.6
441
2993
TAB00
NOMESCO Finland
Lumbar puncture
2.8
16.5
86
322
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
6.2
16.4
28
46
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
16.4
160
795
M54.5
ICD-10 Finland
Low back pain
1.6
16.4
586
4271
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.0
16.3
203
1101
H02AB09
ATC
hydrocortisone; systemic
3.5
16.3
55
159
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
16.3
533
3803
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
7.1
16.1
24
34
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.9
16.1
241
1390
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.6
16.0
97
392
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
16.0
1084
9085
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.9
15.9
223
1259
R20.2
ICD-10 Finland
Paraesthesia of skin
2.3
15.7
122
552
A46
ICD-10 Finland
Erysipelas
1.8
15.7
290
1781
L01
ICPC
Neck symptom/complaint
1.8
15.7
275
1664
M30.0
ICD-10 Finland
Polyarteritis nodosa
161.5
15.5
16
*
R42
ICD-10 Finland
Dizziness and giddiness
1.6
15.3
452
3139
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.0
15.3
167
865
E0000UV, ,
ATC
1.5
15.3
666
5053
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.3
15.2
125
579
M79.7
ICD-10 Finland
Fibromyalgia
3.1
15.2
64
213
R05
ICPC
Cough
1.6
15.1
419
2864
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
5.2
15.1
31
61
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
15.0
450
3136
J01FA10
ATC
azithromycin; systemic
1.5
14.8
804
6375
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
14.7
295
1851
A02BC03
ATC
lansoprazole; oral
1.6
14.7
506
3635
N05CF01
ATC
zopiclone; oral
1.5
14.7
581
4306
L18
ICPC
Muscle pain
2.6
14.7
86
342
G50.1
ICD-10 Finland
Atypical facial pain
3.7
14.6
46
127
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
14.4
390
2648
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.8
14.2
74
277
PD5AD
NOMESCO Finland
CT of aorta
3.0
14.1
62
211
PA6AD
NOMESCO Finland
CT of neck arteries
2.5
14.1
86
349
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.1
14.1
143
721
Z71.8
ICD-10 Finland
Other specified counselling
1.5
14.0
518
3773
WZC30
NOMESCO Finland
Teaching
1.7
14.0
293
1858
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.3
14.0
103
455
L03
ICPC
Low back symptom/complaint
1.6
14.0
473
3377
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
14.0
322
2096
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
13.9
241
1449
J01MA12
ATC
levofloxacin; systemic
1.7
13.9
336
2214
SPAT1153
SPAT
Removal of sutures
1.5
13.8
563
4189
H47.1
ICD-10 Finland
Papilloedema, unspecified
10.5
13.7
26
25
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
13.7
1035
8725
H02AB04
ATC
methylprednisolone; systemic
1.7
13.6
250
1529
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
13.5
176
969
SPAT1263
SPAT
Sampling
1.5
13.4
680
5282
L08
ICPC
Shoulder symptom/complaint
1.6
13.4
391
2696
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
13.4
170
928
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.0
13.3
152
800
J01FA06
ATC
roxithromycin; oral
1.5
13.2
642
4943
A07EC01
ATC
sulfasalazine; oral, rectal
2.1
13.1
135
683
R03BB04
ATC
tiotropium bromide; inhalant
1.8
13.1
203
1180
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.9
13.0
60
210
G45.3
ICD-10 Finland
Amaurosis fugax
3.1
12.9
55
184
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
12.9
321
2128
F29
ICPC
Eye symptom/complaint other
1.9
12.8
184
1045
A11
ICPC
Chest pain NOS
1.9
12.8
180
1016
R74
ICPC
Upper respiratory infection acute
1.6
12.7
388
2699
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
12.7
230
1400
B01AC04
ATC
clopidogrel; oral
1.6
12.6
344
2329
R52.2
ICD-10 Finland
Other chronic pain
2.5
12.6
79
325
R60.0
ICD-10 Finland
Localized oedema
1.7
12.5
258
1627
M31.1
ICD-10 Finland
Thrombotic microangiopathy
131.0
12.4
13
*
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.6
12.4
41
117
TNG10
NOMESCO Finland
Puncture of knee
4.5
12.4
30
68
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.3
12.4
46
142
Z3231
NOMESCO Finland
Registered nurse
1.5
12.3
452
3270
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.8
12.3
190
1102
L20
ICPC
Joint symptom/complaint NOS
2.6
12.3
74
298
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
12.3
248
1555
CS494
NOMESCO Finland
Other visual field testing
2.7
12.3
64
240
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
12.2
785
6348
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
12.2
117
577
R03DC03
ATC
montelukast; oral
1.7
12.2
248
1558
H53.4
ICD-10 Finland
Visual field defects
3.1
12.2
50
164
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
12.1
686
5413
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
3.5
12.1
41
119
S97
ICPC
Chronic ulcer skin
2.0
12.0
141
748
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
5.7
12.0
22
39
UJF92
NOMESCO Finland
Capsular endoscopy
3.4
11.9
43
130
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
11.9
218
1329
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
11.8
270
1747
N02BF01
ATC
gabapentin; oral
1.8
11.8
189
1108
PD5BD
NOMESCO Finland
Extensive CT of aorta
3.3
11.8
44
136
C08CA01
ATC
amlodipine; oral
1.4
11.8
748
6020
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
11.8
437
3165
R55
ICD-10 Finland
Syncope and collapse
1.7
11.8
221
1358
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
11.6
921
7718
GD1AD
NOMESCO Finland
Thorax CT examination
2.0
11.5
123
632
L99
ICPC
Musculoskeletal disease other
3.0
11.5
50
170
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
11.5
11
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
11.4
297
1983
4AC07, ,
NOMESCO Finland
120.8
11.4
12
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
11.4
313
2118
XF402
NOMESCO Finland
ECG with work load test
1.7
11.4
201
1214
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
11.3
294
1962
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
8.4
11.3
24
29
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
11.2
286
1900
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
11.2
231
1454
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
11.2
94
440
R21
ICPC
Throat symptom/complaint
1.7
11.2
242
1544
J05AB01
ATC
aciclovir; systemic
1.5
11.1
353
2468
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
11.1
154
864
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.0
11.0
118
606
R04.2
ICD-10 Finland
Haemoptysis
2.5
11.0
71
296
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.0
11.0
128
678
Z01.2
ICD-10 Finland
Dental examination
1.4
11.0
642
5072
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.8
10.9
171
996
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
10.9
472
3520
D01
ICPC
Abdominal pain/cramps general
1.7
10.9
190
1143
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.6
10.9
60
232
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.5
10.8
70
293
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.0
10.8
30
76
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
10.8
320
2203
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
10.7
350
2460
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
10.7
401
2903
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
10.7
117
606
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
11.3
10.6
19
17
J31.0
ICD-10 Finland
Chronic rhinitis
2.0
10.5
123
652
J02AC01
ATC
fluconazole; systemic
1.4
10.5
554
4285
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.1
10.5
42
136
R63.4
ICD-10 Finland
Abnormal weight loss
2.2
10.5
86
399
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.9
10.5
136
747
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
10.4
10
*
4AC0X, ,
NOMESCO Finland
+∞
10.4
10
*
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
10.4
567
4409
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
10.4
125
670
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.0
10.3
107
544
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
10.3
216
1366
B01AF02
ATC
apixaban; oral
1.6
10.3
291
1980
R01AD08
ATC
fluticasone; nasal
1.5
10.3
386
2793
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.5
10.2
34
98
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
10.2
204
1274
H92.0
ICD-10 Finland
Otalgia
2.1
10.1
94
458
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.3
10.1
77
346
M10.9
ICD-10 Finland
Gout, unspecified
1.9
10.1
138
771
G47.3
ICD-10 Finland
Sleep apnoea
1.5
10.1
328
2301
H34.2
ICD-10 Finland
Other retinal artery occlusions
5.1
10.1
21
42
L01AA01
ATC
cyclophosphamide; systemic
8.5
10.1
21
25
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.2
10.0
38
119
SPAT1260
SPAT
Consultation of another employee
1.6
10.0
290
1982
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
9.9
240
1573
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
9.9
303
2097
R07.3
ICD-10 Finland
Other chest pain
1.7
9.9
186
1142
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.8
9.8
166
988
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.4
9.8
629
5021
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.4
9.8
65
275
B02.9
ICD-10 Finland
Zoster without complication
1.9
9.8
136
764
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.1
9.8
89
431
H26.4
ICD-10 Finland
After-cataract
1.6
9.7
239
1572
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.0
9.7
100
507
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.9
9.7
122
663
H26.3
ICD-10 Finland
Drug-induced cataract
7.4
9.7
22
30
G50.0
ICD-10 Finland
Trigeminal neuralgia
3.0
9.7
43
148
J01FA09
ATC
clarithromycin; systemic
1.5
9.7
439
3292
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
2.9
9.6
44
154
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.8
9.6
139
790
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.3
9.6
36
112
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
9.6
134
754
NXL00
NOMESCO Finland
Biopsy of muscle
11.4
9.6
17
15
R03BA05
ATC
fluticasone; inhalant
1.6
9.6
272
1851
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.6
9.5
54
212
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.3
9.4
70
312
M31.7
ICD-10 Finland
Microscopic polyangiitis
+∞
9.4
9
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.2
9.4
81
384
SPAT1301
SPAT
No procedures
1.4
9.4
526
4096
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
9.3
632
5083
JN4BD
NOMESCO Finland
Extensive body CT
1.7
9.3
192
1208
SPAT1310
SPAT
Counselling related to known health issue
1.4
9.2
496
3830
K02.1
ICD-10 Finland
Caries of dentine
1.4
9.2
786
6562
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
9.1
251
1693
C08CA05
ATC
nifedipine; systemic
1.9
9.1
113
611
N06AX21
ATC
duloxetine; oral
1.7
9.1
180
1119
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
7.1
9.0
21
30
M05.2
ICD-10 Finland
Rheumatoid vasculitis
36.9
9.0
11
*
R01AD12
ATC
fluticasone furoate; nasal
1.5
9.0
380
2804
G43.9
ICD-10 Finland
Migraine, unspecified
2.4
9.0
62
267
WZA90
NOMESCO Finland
Other medical or dental certificate
1.5
9.0
337
2431
R07.0
ICD-10 Finland
Pain in throat
2.1
9.0
86
425
R01AD09
ATC
mometasone; nasal
1.4
9.0
609
4893
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
8.9
608
4888
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
2.4
8.8
60
257
A07AA02
ATC
nystatin; oral
1.9
8.8
115
633
ZXA00
NOMESCO Finland
Right side
1.4
8.8
460
3530
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.9
8.8
105
561
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.9
8.8
118
656
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.4
8.8
60
258
M48.0
ICD-10 Finland
Spinal stenosis
1.6
8.8
245
1659
ZXE00
NOMESCO Finland
One hour or less
1.4
8.7
581
4647
ZYC01
NOMESCO Finland
Remote contact by phone
2.0
8.7
93
478
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
8.7
381
2832
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
7.7
8.6
19
25
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
8.5
297
2107
M13.0
ICD-10 Finland
Polyarthritis, unspecified
3.8
8.5
25
66
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.5
8.5
52
212
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
8.5
191
1227
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
8.5
222
1480
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
90.5
8.4
9
*
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
8.4
436
3337
H05AA02
ATC
teriparatide; parenteral
4.9
8.4
18
37
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
2.5
8.4
50
202
4AC0L, ,
NOMESCO Finland
+∞
8.3
8
*
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
8.3
8
*
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
+∞
8.3
8
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
8.3
132
772
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
8.3
306
2198
R03BA02
ATC
budesonide; inhalant
1.5
8.3
271
1899
D07AC01
ATC
betamethasone; topical
1.4
8.3
556
4446
J20
ICD-10 Finland
Acute bronchitis
1.7
8.2
159
983
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
8.2
103
560
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.8
8.2
124
715
M01AE02
ATC
naproxen; oral, rectal
1.4
8.2
802
6797
SPAT1081
SPAT
Cardiorespiratory global assessment
1.9
8.1
107
591
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.6
8.1
19
42
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
3.5
8.1
27
78
Z2221
NOMESCO Finland
Medical doctor
1.4
8.1
408
3105
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.9
8.1
97
520
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.8
8.1
40
147
SFA30
NOMESCO Finland
Three-surface restoration
1.4
8.1
597
4843
TGC00
NOMESCO Finland
Bronchial lavation
2.5
8.0
48
194
H29
ICPC
Ear symptom/complaint other
1.6
8.0
210
1400
L29
ICPC
Musculoskeletal sympt/complt other
1.7
8.0
152
935
SDA03
NOMESCO Finland
Periodontal treatment
1.4
8.0
534
4260
L07
ICPC
Jaw symptom/complaint
3.9
8.0
23
60
K11.2
ICD-10 Finland
Sialoadenitis
2.4
8.0
52
219
C10AA05
ATC
atorvastatin; oral
1.3
8.0
755
6358
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
7.9
119
685
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
7.9
460
3587
SFA10
NOMESCO Finland
One-surface restoration
1.3
7.9
755
6364
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
7.8
145
886
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.2
7.8
30
95
Z00.0
ICD-10 Finland
General medical examination
1.5
7.8
306
2220
XF404
NOMESCO Finland
Ambulatory ECG
1.7
7.8
155
965
A05AA02
ATC
ursodeoxycholic acid; oral
3.7
7.7
24
66
J01CF05
ATC
flucloxacillin; systemic
1.8
7.7
110
623
K30
ICD-10 Finland
Functional dyspepsia
1.6
7.7
171
1095
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.3
7.7
57
254
WVA20
NOMESCO Finland
Medicine administration
2.3
7.7
54
235
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
7.7
109
616
318
Kela drug reimbursment
Teriparatide
4.4
7.7
19
44
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.8
7.6
122
716
B01AA03
ATC
warfarin; systemic
1.4
7.6
361
2714
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.1
7.6
31
102
PAA99
NOMESCO Finland
Exploration of other arterial branch originating from aortic arch arteries
25.1
7.6
10
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
7.5
169
1085
N06AX11
ATC
mirtazapine; oral
1.4
7.5
525
4209
E000002, ,
ATC
1.7
7.5
140
857
A29
ICPC
General symptom/complaint other
1.5
7.5
238
1654
R06AE07
ATC
cetirizine; oral
1.3
7.5
611
5015
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.3
7.5
56
251
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.3
7.5
55
245
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.5
7.4
25
73
R04.0
ICD-10 Finland
Epistaxis
1.7
7.4
138
845
K07.60
ICD-10 Finland
Snapping jaw
2.2
7.4
59
272
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.6
7.4
166
1067
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
7.4
92
500
N03
ICPC
Pain face
4.0
7.4
20
50
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.6
7.3
163
1044
R13
ICD-10 Finland
Dysphagia
1.7
7.3
127
762
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.5
7.3
262
1866
K04.1
ICD-10 Finland
Necrosis of pulp
1.7
7.3
138
848
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
+∞
7.3
7
*
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.4
7.3
46
191
A02BA02
ATC
ranitidine; systemic
1.4
7.3
331
2467
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
4.2
7.3
19
46
XKD00
NOMESCO Finland
Uroflowmetry
1.5
7.3
249
1758
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.7
7.3
128
772
G44.8
ICD-10 Finland
Other specified headache syndromes
3.4
7.3
25
74
M45
ICD-10 Finland
Ankylosing spondylitis
3.0
7.2
31
105
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.7
7.2
133
811
M02AA07
ATC
piroxicam; topical
1.3
7.2
592
4856
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
4.3
7.2
18
42
A01AB10
ATC
natamycin; local oral
2.3
7.2
50
217
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
7.2
369
2809
D07AD01
ATC
clobetasol; topical
1.5
7.2
254
1804
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
3.7
7.2
22
60
ZY010
NOMESCO Finland
Hospital outpatient
2.2
7.2
59
275
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
7.2
262
1874
UKC02
NOMESCO Finland
Cystoscopy
1.5
7.1
272
1961
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
7.1
85
455
R10.0
ICD-10 Finland
Acute abdomen
2.3
7.1
50
218
XG410
NOMESCO Finland
Flow-volume spirometry
2.1
7.1
67
330
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
7.1
419
3267
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.2
7.1
59
277
K92.1
ICD-10 Finland
Melaena
1.8
7.1
103
588
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.2
7.1
57
264
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.7
7.0
143
896
SFA20
NOMESCO Finland
Two-surface restoration
1.3
7.0
770
6580
PA7BD
NOMESCO Finland
CT angiography of neck and brain
2.7
7.0
37
141
R81
ICPC
Pneumonia
2.1
7.0
67
332
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
7.0
102
583
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.6
6.9
187
1254
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
6.9
480
3834
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
6.9
98
555
I20.09
ICD-10 Finland
Unstable angina
1.7
6.9
115
683
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
6.9
296
2182
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
2.8
6.9
34
125
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.3
6.9
48
209
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
3.6
6.9
22
62
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
6.8
577
4747
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
6.8
426
3349
L60.0
ICD-10 Finland
Ingrowing nail
1.9
6.8
80
427
R96
ICPC
Asthma
1.6
6.8
165
1081
H46
ICD-10 Finland
Optic neuritis
5.7
6.8
18
32
D11
ICPC
Diarrhoea
1.6
6.8
155
1001
J05AB11
ATC
valaciclovir; oral
1.5
6.7
223
1563
R09.1
ICD-10 Finland
Pleurisy
2.8
6.7
33
121
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
2.0
6.7
75
393
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
6.7
463
3694
I73.0
ICD-10 Finland
Raynaud syndrome
3.4
6.7
23
68
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.4
6.7
23
68
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
6.7
505
4083
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.0
6.7
69
352
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.2
6.6
54
251
UDM02
NOMESCO Finland
Sinoscopy
2.6
6.6
36
139
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.4
6.6
42
175
SPAT1211
SPAT
Application of soft bandage
1.6
6.6
142
902
A01AB09
ATC
miconazole; local oral
1.6
6.6
145
926
R11
ICD-10 Finland
Nausea and vomiting
1.6
6.6
147
942
SPAT1360
SPAT
Extensive global examination
1.7
6.6
116
699
M01AH05
ATC
etoricoxib; oral
1.3
6.6
879
7689
ED1AA
NOMESCO Finland
Mandibular X-ray examination
5.5
6.6
18
33
M01AH03
ATC
valdecoxib; oral
1.8
6.6
96
548
XW000
NOMESCO Finland
Bone marrow biopsy
1.9
6.6
77
410
H25.0
ICD-10 Finland
Senile incipient cataract
1.7
6.6
131
817
WZA10
NOMESCO Finland
Extensive medical or dental certificate
3.3
6.6
24
74
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
2.6
6.5
37
146
S29
ICPC
Skin symptom/complaint other
1.4
6.5
328
2485
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
6.9
6.5
15
22
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
6.5
1107
10008
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
6.5
552
4539
C09AA05
ATC
ramipril; oral
1.3
6.5
455
3637
F01
ICPC
Eye pain
2.3
6.5
45
196
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.7
6.5
115
696
WX290
NOMESCO Finland
Other blockage of nerve
1.3
6.5
536
4390
M81.4
ICD-10 Finland
Drug-induced osteoporosis
5.7
6.5
17
30
M01AH02
ATC
rofecoxib; oral
1.5
6.4
222
1568
M13.8
ICD-10 Finland
Other specified arthritis
3.9
6.4
18
46
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.6
6.4
166
1102
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
6.4
114
689
WYA10
NOMESCO Finland
Emergency care or similar visit
1.8
6.4
96
553
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
6.4
199
1376
M04AA01
ATC
allopurinol; systemic
1.5
6.4
230
1638
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
3.0
6.4
27
91
N30.0
ICD-10 Finland
Acute cystitis
1.4
6.4
288
2140
M01AH01
ATC
celecoxib; oral
1.4
6.4
288
2140
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.8
6.4
90
509
H53.8
ICD-10 Finland
Other visual disturbances
2.9
6.4
29
102
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.0
6.4
67
344
H25.8
ICD-10 Finland
Other senile cataract
1.5
6.4
236
1691
SPAT1262
SPAT
Handing over of treatment supplies
1.4
6.4
285
2115
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
3.8
6.4
19
51
WX892
NOMESCO Finland
Monitored bed care
1.7
6.4
126
785
SPAT1312
SPAT
General health counselling
1.3
6.3
451
3610
N06AA09
ATC
amitriptyline; systemic
1.6
6.3
163
1082
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
3.6
6.3
20
56
ZXA10
NOMESCO Finland
Bilateral
1.4
6.3
309
2329
R01AD01
ATC
beclometasone; nasal
1.5
6.3
209
1465
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.1
6.3
57
277
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
3.3
6.3
23
71
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.2
6.3
48
218
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.7
6.3
32
120
J45.8
ICD-10 Finland
Mixed asthma
2.2
6.3
50
231
F05
ICPC
Visual disturbance other
2.1
6.3
59
291
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
6.3
305
2297
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
6.3
6
*
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
6.3
6
*
L86
ICPC
Back syndrome with radiating pain
1.8
6.3
99
580
R83
ICPC
Respiratory infection other
1.4
6.2
248
1801
207
Kela drug reimbursment
Chronic arrhythmias
1.4
6.2
317
2405
7901A
ICD-9 Finland
Nonspecific findings on examination of blood, Elevated sedimentation rate
26.8
6.2
8
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.0
6.2
65
333
R03BA01
ATC
beclometasone; inhalant
1.5
6.2
209
1470
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.0
6.2
64
327
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
3.1
6.2
24
77
J37.0
ICD-10 Finland
Chronic laryngitis
2.1
6.2
54
259
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
6.2
158
1048
K11.70
ICD-10 Finland
Hypoptyalism
5.8
6.1
16
28
D07AC13
ATC
mometasone; topical
1.3
6.1
410
3248
XCK10
NOMESCO Finland
Photography of fundus of eye
1.5
6.1
163
1091
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
4.1
6.1
16
39
EBA10
NOMESCO Finland
Operative extraction of tooth
1.7
6.1
120
747
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
6.0
647
5477
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
6.0
336
2587
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.7
6.0
98
579
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.1
6.0
53
255
C03DA01
ATC
spironolactone; oral
1.5
6.0
225
1615
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
473
577
11.11
307.65
2.1
1.2
22.76
5.00
iu/ml
—
21
5
325
388
10.20
260.35
1.7
1.5
0.09
19.49
iu/ml
0.57
56
69
305
469
7.76
196.00
2.0
1.3
6.59
5.87
iu/ml
0.19
86
98
223
243
10.46
189.37
1.5
1.1
312.00
314.67
titre
0.00
25
15
1321
7413
5.00
163.01
13.5
5.7
0.04
0.04
e9/l
1.19
1198
6205
1319
7394
4.98
162.98
13.5
5.7
0.65
0.61
e9/l
8.10
1198
6177
1325
7535
4.93
158.35
13.6
5.7
1.87
1.89
e9/l
0.22
1229
6480
1332
7635
4.94
156.65
13.8
5.9
0.16
0.19
e9/l
12.56
1226
6505
227
331
7.80
151.64
1.7
1.2
0.26
0.24
g/l
0.90
214
311
231
346
7.61
150.63
1.7
1.2
1.31
1.21
g/l
2.85
219
327
646
2350
3.88
147.90
1.5
1.3
33.02
39.26
iu/ml
0.37
198
727
624
2219
3.92
147.68
1.5
1.2
7.25
15.03
u/ml
2.43
213
765
1209
6832
3.92
135.78
13.9
5.9
2.07
2.80
%
32.99
1176
6324
1205
6798
3.90
135.60
13.7
5.8
62.34
58.21
%
27.24
1177
6433
1215
6950
3.88
132.45
13.9
5.9
23.93
26.33
%
12.80
1187
6521
470
1537
3.88
122.83
1.9
3.0
65.14
66.03
g/l
1.61
426
1396
1334
8420
4.12
118.36
16.0
9.3
5.03
4.19
e9/l
30.90
1220
7217
970
5100
3.20
115.20
2.8
2.2
122.03
222.70
u/l
6.14
931
4793
426
1396
3.77
109.76
2.3
2.2
346.62
392.59
nmol/l
4.97
391
1274
1317
8511
3.77
106.40
9.1
7.2
1.22
1.21
mmol/l
0.65
1188
7318
219
440
5.59
105.52
1.4
1.2
0.16
1.02
u/ml
0.86
16
33
1163
7004
3.26
105.05
3.3
2.4
82.26
80.05
nmol/l
1.88
1094
6137
1221
7662
3.32
100.68
7.4
6.4
1.21
1.21
mmol/l
0.20
1179
7027
343
1056
3.84
95.80
2.5
2.9
9.99
10.99
g/l
3.21
318
958
146
243
6.50
85.13
1.4
1.1
2.64
10.52
u/ml
—
10
10
1464
10814
4.26
82.00
17.2
4.2
17.63
14.38
mm/h
9.73
1430
9967
227
578
4.40
81.69
1.8
1.9
35.06
40.08
u/l
3.37
200
504
264
754
3.98
81.32
1.7
2.6
8.71
7.45
g/l
16.16
238
676
263
753
3.97
80.70
1.7
2.6
3.83
3.73
g/l
0.53
237
676
263
754
3.96
80.54
1.7
2.6
4.18
4.20
g/l
0.17
237
677
281
845
3.81
80.35
1.6
1.9
1.15
1.47
g/l
1.52
260
757
156
298
5.68
78.84
1.5
1.2
13.25
2.92
u/ml
1.08
22
33
250
703
4.02
78.58
1.7
2.7
3.68
2.95
g/l
13.54
223
626
154
297
5.62
76.99
1.5
1.1
7.85
2.91
u/ml
0.99
18
18
237
651
4.09
76.88
1.6
2.7
9.50
10.50
g/l
2.62
208
570
204
543
4.15
68.80
1.7
2.7
0.00
0.02
g/l
1.24
181
482
161
360
4.85
67.81
1.9
2.0
11.73
12.75
mg/l
0.85
148
327
227
661
3.82
67.47
1.9
2.8
0.29
1.46
g/l
5.50
195
554
1171
8010
2.61
67.00
6.8
4.4
0.01
0.19
estimate
0.48
287
1636
1164
7950
2.59
66.63
6.8
4.4
6.32
2.75
estimate
0.23
301
1746
1153
7845
2.58
66.45
6.7
4.4
0.00
0.00
estimate
-0.00
293
1683
263
857
3.46
65.91
2.7
2.6
19.34
23.47
au/ml
0.21
18
60
245
767
3.58
65.30
1.4
1.4
38.05
56.71
au/ml
0.74
12
54
112
191
6.22
63.49
1.4
1.7
0.79
0.82
g/l
0.09
83
151
223
673
3.68
62.71
1.9
3.7
30.98
70.80
mg/l
1.53
188
583
223
675
3.67
62.42
1.9
3.7
37.86
63.41
mg/l
1.67
188
583
192
527
3.99
61.87
1.8
2.7
0.00
0.00
g/l
-0.00
164
458
181
489
4.04
59.56
1.7
2.8
0.00
0.00
g/l
-0.00
164
458
759
4442
2.32
59.22
2.9
2.4
2.96
2.98
mg/l
0.08
667
3790
231
754
3.40
57.36
3.0
2.2
0.00
1.15
estimate
0.50
76
218
551
2850
2.40
56.73
2.9
2.6
10.93
12.08
umol/l
3.35
508
2638
441
2072
2.54
55.91
3.4
4.1
236.90
249.04
u/l
0.74
411
1951
225
738
3.37
55.36
1.8
1.9
1.81
1.89
ug/l
0.04
192
645
200
609
3.60
55.24
1.7
3.5
1.35
4.22
ratio
2.07
117
362
1452
11520
3.25
54.56
15.2
8.4
74.34
81.22
u/l
8.15
1428
10828
520
2683
2.37
53.27
2.8
2.6
2.22
2.28
g/l
1.49
474
2457
963
6413
2.21
52.61
22.2
12.1
0.00
0.00
e9/l
0.56
816
5180
92
159
6.07
51.36
1.2
1.0
—
—
—
0
0
490
2497
2.37
51.35
2.9
2.6
19.39
21.49
%
2.83
446
2309
496
2571
2.33
49.72
1.6
1.5
2.41
2.59
g/l
1.25
339
1449
58
63
9.51
48.54
1.1
1.0
6.08
7.57
u/l
0.23
43
53
554
3061
2.22
47.21
2.5
1.9
—
—
—
0
0
947
6462
2.10
46.05
3.9
3.1
173.86
138.81
ug/l
2.54
878
5898
1229
9275
2.29
46.00
6.4
5.1
6.77
6.83
mmol/l
0.54
1194
8859
63
82
7.95
45.69
1.1
1.1
—
—
—
0
0
103
220
4.93
45.56
1.4
1.1
61.50
14.80
u/ml
—
8
17
114
275
4.38
43.39
2.9
4.7
291.42
408.54
iu/ml
0.31
12
37
356
1683
2.42
43.29
2.4
2.5
70.03
69.01
e9/l
0.19
265
1249
812
5349
2.02
42.15
4.7
3.5
30.47
73.75
e6/l
2.35
671
4130
874
5930
2.01
41.51
6.1
4.1
105.52
115.26
e6/l
0.12
675
4267
64
95
6.97
41.34
1.4
1.1
269.23
156.00
titre
0.34
13
15
56
72
8.02
41.01
1.1
1.1
—
—
—
0
0
1294
10186
2.28
40.44
7.4
5.5
369.50
2320.21
e6/l
—
10
165
1033
7474
2.03
40.43
5.7
5.0
33.59
34.85
g/l
10.70
979
6986
1119
8353
2.07
39.87
6.7
6.7
10.27
11.87
umol/l
4.84
1072
7954
53
66
8.26
39.84
1.1
1.1
—
—
—
0
0
53
66
8.26
39.84
1.1
1.1
—
—
—
0
0
720
4633
1.99
39.05
4.4
3.4
0.31
0.51
e6/l
3.17
575
3455
52
65
8.23
38.96
1.1
1.1
—
—
—
0
0
428
2321
2.14
36.76
2.3
1.8
—
—
—
0
0
93
219
4.44
36.46
1.7
2.5
165.00
1535.42
u/ml
—
5
19
50
65
7.90
36.26
1.1
1.1
—
—
—
0
0
747
4976
1.92
35.60
3.1
2.6
57.33
62.49
u/l
0.92
698
4579
627
3941
1.96
35.55
3.1
2.9
337.38
350.04
umol/l
2.06
548
3364
696
4557
1.92
34.70
7.2
4.4
0.00
0.00
estimate
0.96
281
1539
132
426
3.28
32.88
1.5
1.4
—
—
—
0
0
596
3768
1.91
32.55
3.6
2.7
4.62
5.63
e6/l
1.47
553
3425
313
1572
2.22
32.18
2.2
2.2
204.18
142.98
ug/g
1.05
250
1245
78
177
4.58
32.01
1.6
1.5
54.30
64.94
%
1.22
50
111
394
2169
2.07
31.95
2.3
1.9
—
—
—
0
0
1045
7953
1.86
31.02
22.0
18.0
1.31
1.32
inr
0.14
907
6645
203
859
2.56
30.68
1.5
1.7
2.05
1.56
g/l
6.02
168
745
821
5913
1.78
28.15
3.2
3.6
2.35
2.36
mmol/l
2.37
734
5310
158
621
2.71
27.63
2.1
2.2
259.06
875.23
ug/l
1.15
142
593
866
6380
1.76
27.03
6.3
4.4
34.11
63.15
ng/l
1.54
703
5026
506
3196
1.84
26.62
2.1
1.7
1.36
1.52
mg/l
0.46
413
2532
104
332
3.28
26.32
1.2
1.2
3.76
3.88
mmol/l
0.64
95
316
798
5809
1.73
25.43
3.7
3.2
1579.68
1571.27
ng/l
0.02
723
5074
30
32
9.53
25.34
1.2
1.1
—
—
—
0
0
102
330
3.23
25.25
1.2
1.2
—
—
—
0
0
30
33
9.24
24.77
1.1
1.0
—
—
—
0
0
250
1273
2.14
24.35
1.8
1.7
—
—
—
0
0
109
376
3.03
24.21
1.3
1.3
469.81
552.43
mg/l
1.21
102
357
974
7580
1.70
23.49
2.6
2.3
91.92
94.95
pmol/l
1.20
542
3878
461
2924
1.80
23.40
4.1
3.1
1.65
1.18
e6/l
0.27
285
1599
1520
13641
2.54
22.62
41.4
18.6
24.82
26.70
mg/l
1.64
1463
11510
890
6806
1.67
22.54
3.0
2.4
—
—
—
0
0
784
5835
1.66
21.80
6.8
4.5
0.42
0.44
estimate
0.02
252
1364
712
5171
1.67
21.77
2.0
1.8
19.03
20.30
nmol/l
1.67
608
4271
490
3223
1.74
21.66
2.0
1.8
1106.64
1170.64
nmol/l
0.85
369
2385
584
4040
1.69
21.41
4.5
3.4
0.73
0.01
0.46
11
139
408
2566
1.79
20.97
2.4
2.0
29.36
29.61
s
0.31
399
2486
65
179
3.74
20.63
3.4
3.7
58.31
59.04
%
0.10
59
157
52
122
4.37
20.49
1.1
1.1
—
—
—
0
0
105
396
2.76
19.82
1.8
1.7
11282.20
16456.94
e6/l
0.94
83
285
68
202
3.47
19.29
1.2
1.2
281.11
288.22
u/ml
0.05
38
106
1272
10899
1.74
19.09
5.4
4.5
15.48
15.10
pmol/l
6.20
1182
9792
430
2809
1.72
19.09
2.8
3.0
0.81
0.81
mmol/l
0.15
398
2628
39
77
5.16
18.88
1.2
1.1
—
—
—
0
0
92
337
2.83
18.35
1.5
1.4
—
—
—
0
0
248
1392
1.92
18.12
4.7
3.9
1.22
1.23
mmol/l
0.51
229
1180
271
1575
1.86
17.76
1.5
1.3
—
—
—
0
0
411
2698
1.70
17.74
4.2
3.2
3.92
2.58
e6/l
1.09
230
1361
563
4006
1.62
17.71
5.8
3.9
0.98
0.06
estimate
0.46
256
1303
41
92
4.55
17.10
1.3
1.2
1.93
2.15
mmol/l
1.03
36
85
81
292
2.87
16.65
1.4
1.4
—
—
—
0
0
250
1464
1.83
15.89
3.5
3.6
88.26
92.64
ng/l
0.29
222
1232
76
275
2.85
15.52
1.2
1.3
—
—
—
0
0
354
2310
1.68
15.35
6.5
5.1
1.05
1.04
mmol/l
0.61
335
2114
258
1547
1.79
15.12
7.1
6.3
10.46
10.94
mmol/l
0.50
251
1478
514
3692
1.57
15.01
2.8
3.1
2.48
2.47
mmol/l
0.83
457
3322
263
1590
1.78
14.98
6.8
7.0
1.38
1.34
mmol/l
0.24
252
1570
48
135
3.63
14.82
1.4
1.5
33.43
30.50
%
0.19
28
81
103
444
2.41
14.80
1.7
1.5
—
—
—
0
0
431
2979
1.61
14.80
1.4
1.3
1.35
1.36
u/ml
0.01
102
751
51
151
3.45
14.59
1.1
1.2
—
—
—
0
0
77
295
2.69
14.13
1.5
1.4
—
—
—
0
0
210
1208
1.85
14.05
2.0
1.7
—
—
—
0
0
31
65
4.84
14.04
1.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
69
4.71
14.02
1.1
1.2
—
—
—
0
0
42
112
3.82
14.01
1.1
1.1
—
—
—
0
0
469
3347
1.56
13.90
6.3
4.1
129.73
365.59
ng/l
4.23
405
2868
97
419
2.40
13.88
1.9
1.5
—
—
—
0
0
253
1548
1.75
13.76
3.2
2.6
5.57
6.80
ug/l
0.70
213
1357
249
1517
1.76
13.75
2.7
2.3
30.72
37.57
u/l
2.80
201
1253
1422
12896
1.77
13.71
6.9
5.7
1.86
2.03
mu/l
5.47
1328
11669
58
195
3.05
13.52
1.2
1.3
163.85
157.55
au/ml
0.14
17
63
278
1762
1.70
13.28
4.1
3.4
2.03
1.88
mmol/l
0.33
250
1510
127
626
2.11
13.25
2.9
2.7
—
—
—
0
0
77
305
2.60
13.24
1.5
1.4
—
—
—
0
0
1009
8505
1.48
13.01
4.2
3.3
53.73
53.72
u/l
0.00
947
7793
1444
13197
1.78
12.97
8.7
7.3
41.07
40.24
mmol/mol
3.10
1373
12111
65
239
2.79
12.92
1.5
1.4
—
—
—
0
0
79
325
2.50
12.58
1.2
1.2
21.33
54.11
e6/l
0.56
55
239
32
76
4.27
12.47
1.0
1.0
—
—
—
0
0
27
56
4.89
12.39
1.1
1.1
1819.22
1704.59
miu/ml
0.18
27
56
79
328
2.48
12.34
1.2
1.3
1818.59
769.36
e6/l
0.28
59
257
282
1829
1.65
12.28
4.0
3.4
5.77
5.80
kpa
0.26
274
1776
103
487
2.19
11.95
1.4
1.4
279.16
279.49
ug/g
0.00
51
296
145
781
1.94
11.84
1.4
1.2
184.01
213.94
u/ml
0.22
134
713
90
405
2.29
11.76
1.7
1.5
—
—
—
0
0
531
4015
1.48
11.57
5.1
4.1
89.11
86.17
%
1.95
520
3925
161
906
1.86
11.50
1.6
1.5
—
—
—
0
0
98
463
2.19
11.40
1.6
1.6
—
—
—
0
0
73
306
2.45
11.19
1.2
1.1
—
3.05
—
0
25
82
364
2.32
11.07
1.3
1.4
—
—
—
0
0
82
364
2.32
11.07
1.3
1.4
—
—
—
0
0
25
54
4.69
10.96
1.2
1.1
73.71
512.93
ng/l
—
7
14
32
85
3.82
10.77
1.1
1.1
34.37
38.67
mg/l
0.33
27
75
48
166
2.95
10.71
1.9
1.7
—
—
—
0
0
309
2114
1.57
10.68
7.0
6.9
4.99
5.10
kpa
1.15
296
2029
309
2114
1.57
10.68
7.0
6.9
12.28
12.18
kpa
0.10
296
2031
1229
10954
1.48
10.63
42.1
23.5
14.25
13.87
%
15.68
1222
10791
595
4659
1.43
10.56
3.1
3.2
30.18
34.86
u/l
2.12
552
4376
1432
13206
1.66
10.55
31.5
19.0
72.46
73.22
ml/min/173m2
0.78
1392
12385
280
1883
1.59
10.40
7.3
7.2
95.47
95.35
%
0.09
271
1820
264
1755
1.60
10.29
7.7
7.6
118.11
119.05
g/l
0.35
257
1713
117
618
1.96
10.12
2.2
1.8
—
—
—
0
0
53
202
2.68
9.90
1.5
1.4
—
—
—
0
0
43
148
2.96
9.70
1.1
1.1
—
1.75
—
0
18
261
1760
1.57
9.54
2.5
2.6
7.50
8.43
umol/l
0.34
232
1563
84
403
2.14
9.44
1.7
1.5
—
—
—
0
0
20
25
8.08
9.34
1.4
1.5
—
—
—
0
0
301
2106
1.53
9.31
7.1
6.9
0.79
0.90
mmol/l
0.18
253
1734
1517
14294
1.81
9.25
36.3
23.2
139.37
139.60
mmol/l
2.67
1507
14010
848
7166
1.38
9.24
3.2
2.9
—
—
estimate
—
0
0
1513
14255
1.78
9.10
25.0
13.1
23.44
24.20
u/l
1.36
1494
13752
245
1651
1.57
8.95
2.3
2.1
0.22
0.20
g/l
1.97
221
1529
43
155
2.82
8.95
1.3
1.2
11.60
4.54
u/ml
0.38
15
46
77
365
2.16
8.93
1.7
1.6
—
—
—
0
0
1516
14305
1.78
8.87
37.0
23.4
3.97
3.99
mmol/l
3.12
1504
13998
26
69
3.81
8.80
2.2
1.9
497.90
557.35
e6/l
0.15
21
57
43
157
2.79
8.74
2.0
1.7
—
—
—
0
0
212
1391
1.60
8.67
3.3
2.4
0.21
0.53
e6/l
3.13
201
1328
63
282
2.28
8.41
2.0
1.6
—
—
—
0
0
1526
14460
1.78
8.34
44.3
25.6
84.66
80.34
umol/l
2.81
1516
14275
229
1544
1.56
8.32
3.5
2.9
4.46
4.43
kpa
0.11
221
1498
117
669
1.81
7.96
2.4
2.0
—
—
—
0
0
89
466
1.96
7.94
4.6
3.6
1.86
1.91
index
0.04
49
229
77
386
2.04
7.76
1.2
1.2
—
—
—
0
0
31
101
3.11
7.72
2.5
2.4
57.75
51.32
iu/ml
—
8
16
40
152
2.67
7.58
1.3
1.2
4.06
6.25
u/ml
0.50
17
69
77
390
2.02
7.55
1.2
1.2
—
—
—
0
0
26
77
3.41
7.54
1.3
1.3
—
—
—
0
0
26
77
3.41
7.54
1.3
1.3
—
—
—
0
0
172
1111
1.61
7.49
8.1
8.6
24.43
24.27
mmol/l
0.30
167
1088
107
607
1.82
7.48
4.4
3.9
24.81
25.06
mmol/l
0.41
97
556
174
1129
1.61
7.44
4.8
3.6
5.10
5.19
kpa
0.81
165
1081
1426
13353
1.52
7.42
6.2
5.5
4.50
4.51
mmol/l
0.08
1326
12165
153
962
1.65
7.42
4.1
3.5
1.76
2.20
mmol/l
0.85
116
724
63
299
2.15
7.33
1.6
1.9
4.58
4.67
mmol/24h
0.07
56
251
72
360
2.05
7.32
1.8
1.8
4.03
20.88
iu/l
0.48
20
136
1416
13250
1.50
7.29
6.1
5.4
1.54
1.48
mmol/l
4.24
1307
11966
1435
13465
1.52
7.29
6.8
5.8
5.94
6.07
mmol/l
3.02
1317
12066
88
474
1.91
7.24
1.4
1.3
—
—
—
0
0
46
192
2.44
7.22
3.8
3.5
—
—
—
0
0
22
60
3.70
7.19
1.0
1.1
—
73.43
%
—
0
7
170
1106
1.60
7.19
8.0
7.5
24.77
24.91
mmol/l
0.20
170
1101
106
609
1.79
7.12
1.4
1.3
—
—
—
0
0
1527
14557
1.70
7.01
53.1
28.6
92.05
91.78
fl
1.45
1519
14357
1527
14557
1.70
7.01
53.3
28.7
263.91
245.59
e9/l
19.42
1514
14221
1365
12705
1.44
7.00
5.1
4.6
1.29
1.27
mmol/l
0.47
1243
11327
1527
14559
1.70
6.98
53.3
28.7
4.29
4.37
e12/l
8.47
1510
14155
1527
14559
1.70
6.98
54.0
29.2
39.14
39.40
%
1.44
1519
14353
1527
14562
1.69
6.93
53.6
28.9
128.70
131.77
g/l
15.39
1519
14368
1527
14562
1.69
6.93
53.3
28.7
7.81
6.81
e9/l
45.91
1510
14165
38
148
2.60
6.89
1.5
1.4
18655.52
154592.22
e6/l
1.27
25
103
25
78
3.24
6.71
2.0
1.9
—
—
—
0
0
699
5921
1.31
6.68
2.1
2.0
1.33
1.30
mmol/l
0.41
575
4830
215
1511
1.49
6.40
3.5
3.1
228.47
224.51
ng/l
0.05
197
1391
27
91
3.00
6.39
1.5
1.6
4.16
6.35
u/l
0.54
19
73
31
113
2.78
6.39
1.4
1.2
—
—
—
0
0
29
102
2.88
6.38
1.1
1.0
—
—
—
0
0
22
66
3.37
6.28
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
102
602
1.74
6.28
2.8
2.6
0.43
0.37
iu/ml
0.70
59
331
154
1018
1.57
6.09
9.3
9.1
15.67
15.67
%
0.01
147
979
16
39
4.13
6.09
1.4
1.1
—
—
—
0
0
10
8
12.57
6.08
1.0
1.0
—
—
—
0
0
23
73
3.18
6.02
1.3
1.2
—
—
—
0
0
23
73
3.18
6.02
1.3
1.2
—
—
—
0
0
46
209
2.24
6.01
1.5
1.4
—
—
—
0
0
22
68
3.27
6.01
1.4
1.0
1.18
1.16
u/l
0.03
12
34
87
497
1.79
5.99
1.8
1.6
22.63
22.10
u/ml
0.02
16
72
30
112
2.71
5.94
1.4
1.3
—
—
—
0
0
176
1206
1.51
5.92
1.5
1.4
—
—
—
0
0
16
40
4.03
5.90
1.4
1.1
—
—
—
0
0
91
531
1.76
5.84
1.3
1.3
—
—
—
0
0
15
26
5.81
5.84
1.1
1.1
—
—
—
0
0
131
845
1.60
5.76
3.2
3.3
4.36
4.35
pmol/l
0.01
108
744
22
70
3.17
5.75
1.1
1.2
—
—
—
0
0
43
194
2.25
5.73
1.7
1.5
—
—
—
0
0
45
207
2.21
5.72
1.5
1.4
—
—
—
0
0
1440
13647
1.45
5.67
7.1
6.4
2.50
2.57
mmol/l
2.12
1337
12374
45
208
2.20
5.66
1.5
1.4
—
—
—
0
0
31
122
2.57
5.55
1.3
1.5
—
—
—
0
0
657
5643
1.27
5.27
3.5
3.4
6.85
6.88
mmol/l
0.07
548
4676
31
126
2.49
5.22
1.2
1.3
—
—
—
0
0
164
1139
1.49
5.18
4.2
2.9
126.13
126.59
g/l
0.10
158
1105
239
1781
1.40
5.18
4.3
3.6
—
—
—
0
0
19
59
3.25
5.17
1.3
1.1
0.63
0.49
ratio
—
8
40
483
3998
1.29
5.17
2.8
2.5
—
—
—
0
0
43
203
2.15
5.16
1.5
1.4
—
—
—
0
0
433
3540
1.30
5.08
7.5
4.7
7.25
1.02
kg/l
0.80
324
2389
437
3580
1.30
5.04
1.9
1.8
19155417.32
21160259.37
pmol/l
0.04
355
2897
43
205
2.13
5.04
1.5
1.4
—
—
—
0
0
31
129
2.43
4.98
1.7
1.5
—
—
—
0
0
16
38
4.24
4.82
1.3
1.1
—
—
—
0
0
42
203
2.10
4.77
1.5
1.4
—
—
—
0
0
17
52
3.29
4.75
1.3
1.1
—
—
—
0
0
22
79
2.81
4.72
5.4
3.9
—
—
—
0
0
22
79
2.81
4.72
2.0
1.8
15.23
17.65
%
0.43
22
74
10
14
7.18
4.65
1.5
1.1
—
—
—
0
0
27
110
2.48
4.55
1.3
1.1
—
—
—
0
0
20
70
2.88
4.50
1.3
1.1
—
—
—
0
0
13
28
4.67
4.37
1.7
1.1
—
—
—
0
0
43
218
2.00
4.33
1.6
1.5
—
—
—
0
0
14
33
4.27
4.32
1.4
1.1
—
—
—
0
0
12
24
5.03
4.32
1.0
1.1
—
—
—
0
0
31
140
2.24
4.19
1.8
1.5
—
—
—
0
0
31
140
2.24
4.19
1.8
1.5
—
—
—
0
0
31
140
2.24
4.19
1.8
1.5
—
—
—
0
0
64
374
1.74
4.17
1.8
1.4
—
—
—
0
0
122
836
1.50
4.15
4.6
3.2
25.32
25.30
mmol/l
0.02
114
806
114
777
1.50
3.99
1.1
1.2
150.28
122.27
u/ml
0.27
29
281
37
184
2.03
3.95
1.3
1.2
0.21
0.19
nmol/l
0.49
26
149
14
43
3.28
3.91
1.6
1.4
0.39
0.39
ug/l
—
9
26
648
5696
1.23
3.91
4.3
4.1
13.00
8.32
mg/mmol
1.21
412
3479
58
337
1.75
3.88
5.8
4.7
4.97
5.09
kpa
0.76
58
332
166
1223
1.40
3.86
3.3
2.9
54.46
60.36
ml/min/173m2
1.28
74
547
36
180
2.02
3.80
3.3
3.5
14.43
11.58
index
0.80
23
90
78
494
1.61
3.79
4.2
3.5
0.82
0.80
nmol/l
0.12
61
403
68
418
1.65
3.72
2.9
2.7
1.98
1.69
mg/l
1.39
57
371
14
39
3.61
3.70
1.3
1.1
—
—
—
0
0
10
20
5.02
3.69
1.2
1.2
—
—
—
0
0
10
20
5.02
3.69
1.6
1.2
—
—
—
0
0
14
45
3.13
3.65
1.2
1.1
—
—
—
0
0
36
184
1.98
3.59
1.2
1.3
454.29
286.15
pmol/l
0.63
28
162
36
185
1.97
3.54
1.3
1.7
—
—
—
0
0
13
36
3.63
3.49
1.6
1.4
43.43
19.88
%
—
7
24
22
93
2.38
3.49
1.7
1.4
—
—
—
0
0
150
1116
1.38
3.31
7.0
6.0
24.25
24.37
mmol/l
0.15
144
1064
88
596
1.50
3.22
3.4
2.9
24.51
25.21
mmol/l
1.02
88
585
23
105
2.21
3.10
1.8
1.4
—
—
—
0
0
11
30
3.68
3.08
1.4
1.1
—
—
—
0
0
11
30
3.68
3.08
1.0
1.0
—
—
—
0
0
8
16
5.02
3.05
1.0
1.0
—
—
—
0
0
20
88
2.29
2.94
1.8
1.4
—
—
—
0
0
57
358
1.61
2.93
3.2
2.6
16.03
15.99
%
0.04
57
350
40
228
1.77
2.92
1.3
1.3
30.48
32.67
iu/l
0.16
34
194
86
595
1.47
2.87
4.3
3.5
1.27
1.42
mmol/l
1.13
86
585
32
171
1.89
2.87
1.5
1.5
23.49
30.93
ng/l
0.35
32
171
33
179
1.86
2.83
1.0
1.1
1.54
1.56
g/l
0.11
27
160
9
23
3.93
2.77
8.3
7.1
5.36
5.25
kpa
—
9
23
240
1959
1.26
2.76
11.1
7.9
—
—
—
0
0
7
14
5.02
2.73
1.3
1.4
—
—
—
0
0
120
896
1.37
2.64
4.0
3.9
1.02
1.02
ratio
2.12
109
820
15
61
2.47
2.62
1.5
1.5
52.00
99.21
umol/l
—
10
43
25
127
1.98
2.61
1.2
1.1
12.26
2.53
eliau/ml
—
8
41
29
157
1.86
2.53
1.2
1.7
—
—
—
0
0
14
57
2.47
2.45
1.2
1.2
—
—
—
0
0
28
153
1.84
2.39
1.1
1.1
—
—
—
0
0
240
1994
1.24
2.38
5.7
5.4
34.59
33.72
%
0.54
177
1250
17
77
2.22
2.37
1.8
1.7
37.22
40.03
g/l
1.45
17
77
36
213
1.71
2.37
2.4
2.5
20.94
23.43
mg/l
0.19
12
78
34
198
1.73
2.36
1.1
1.3
10.90
10.21
u/l
0.12
25
152
7
17
4.13
2.36
1.6
1.5
—
—
—
0
0
12
46
2.62
2.36
1.1
1.2
—
—
—
0
0
11
39
2.83
2.34
1.2
1.1
—
—
—
0
0
19
91
2.10
2.33
1.4
1.3
29.32
34.12
u/l
0.28
12
74
44
276
1.61
2.33
2.5
1.8
1.72
1.61
mmol/l
0.34
44
266
6
13
4.63
2.27
1.0
1.3
—
—
—
0
0
8
23
3.49
2.27
1.5
1.2
—
—
—
0
0
109
825
1.34
2.23
5.0
4.3
1.43
1.52
%
0.64
104
783
82
595
1.40
2.18
1.0
1.1
—
—
—
0
0
490
4384
1.17
2.17
6.1
6.2
4.38
3.09
ug/l
0.31
436
3898
7
19
3.70
2.15
1.6
1.1
65.93
167.63
ng/l
—
7
13
7
19
3.70
2.15
1.7
1.5
61.29
43.11
umol/l
—
7
19
16
75
2.14
2.08
2.1
1.6
—
—
—
0
0
16
75
2.14
2.08
2.1
1.6
—
—
—
0
0
16
75
2.14
2.08
2.1
1.6
—
—
—
0
0
16
75
2.14
2.08
2.1
1.6
—
—
—
0
0
11
43
2.57
2.08
1.2
1.1
—
—
—
0
0
9
31
2.91
2.07
1.0
1.4
1.90
2.48
umol/l
—
9
26
53
358
1.50
2.07
1.8
2.6
26.82
34.38
umol/l
2.20
44
311
69
492
1.42
2.04
4.5
3.8
4.00
3.91
mmol/l
0.78
69
486
32
192
1.68
2.04
3.8
2.3
-0.40
0.78
mmol/l
0.94
32
186
11
44
2.51
2.01
1.5
1.1
—
—
—
0
0
231
1947
1.22
2.01
3.0
4.2
19.69
19.74
ug/l
0.00
184
1599
26
148
1.77
1.99
1.4
1.3
—
—
—
0
0
5
11
4.56
1.94
1.0
1.0
83.20
87.27
titre
—
5
11
29
172
1.70
1.93
1.1
1.0
—
—
—
0
0
9
33
2.74
1.93
1.1
1.3
—
—
—
0
0
9
34
2.66
1.86
1.0
1.4
—
—
—
0
0
5
12
4.18
1.82
1.2
1.0
—
—
—
0
0
6
18
3.34
1.74
2.0
1.2
—
—
—
0
0
395
3532
1.16
1.73
5.0
5.1
20.51
21.93
%
1.22
202
1871
11
48
2.30
1.70
1.0
1.4
—
—
—
0
0
6
19
3.17
1.66
3.5
7.8
8.57
10.22
%
—
6
19
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
18
99
1.83
1.57
2.7
1.3
—
—
—
0
0
18
99
1.83
1.57
2.7
1.3
—
—
—
0
0
22
129
1.72
1.57
1.2
1.1
98.14
102.54
pmol/l
0.22
22
129
58
425
1.38
1.53
3.7
2.9
7.93
7.84
kpa
0.17
58
411
11
51
2.16
1.50
1.0
1.0
—
—
—
0
0
107
863
1.26
1.45
1.9
2.4
13.87
12.57
nmol/l
0.83
90
754
55
404
1.37
1.45
1.5
1.5
—
—
—
0
0
5
16
3.13
1.44
14.2
13.0
4.66
5.17
mmol/l
—
5
16
138
1149
1.22
1.41
1.5
1.7
1.68
1.58
%
0.44
117
932
60
451
1.34
1.38
1.5
1.5
—
—
—
0
0
48
349
1.39
1.36
6.5
6.1
103.95
105.28
mmol/l
1.14
43
313
24
151
1.60
1.35
1.7
1.5
19.00
26.35
u/ml
—
6
23
13
68
1.92
1.33
1.2
1.4
7.63
8.75
umol/l
—
7
45
289
2588
1.14
1.25
3.7
3.6
0.72
0.79
ug/l
0.49
212
1827
5
19
2.64
1.21
1.0
1.6
123.20
107.84
%
—
5
19
5
19
2.64
1.21
1.2
1.0
—
—
—
0
0
5
19
2.64
1.21
1.2
1.2
—
—
—
0
0
54
409
1.33
1.21
2.4
2.2
130.34
126.43
g/l
0.78
44
322
11
57
1.94
1.17
1.0
1.3
—
—
—
0
0
5
20
2.50
1.15
1.0
2.2
—
1.76
—
0
11
11
59
1.87
1.07
2.5
1.7
—
—
—
0
0
11
59
1.87
1.07
2.6
1.7
—
—
—
0
0
11
59
1.87
1.07
2.5
1.7
—
—
—
0
0
84
688
1.23
1.05
2.8
3.4
60.91
2405.42
u/ml
0.99
69
600
7
35
2.00
1.00
1.1
1.5
—
—
—
0
0
13
77
1.69
0.95
1.0
1.1
—
—
—
0
0
8
42
1.91
0.88
1.3
1.8
70.63
742.17
nmol/24h
—
8
42
6
32
1.88
0.82
1.5
1.6
—
—
—
0
0
48
382
1.26
0.81
3.2
3.3
174.05
1084.66
u/ml
0.73
43
351
44
347
1.28
0.80
1.3
1.3
—
—
—
0
0
18
122
1.48
0.80
1.9
1.6
8.08
8.54
mmol/l
0.22
18
122
9
53
1.70
0.75
1.0
1.1
—
13.70
—
0
20
14
91
1.54
0.75
1.3
2.1
—
—
—
0
0
27
201
1.35
0.74
1.1
1.1
3.80
115.13
iu/ml
—
5
34
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
54
448
1.21
0.67
1.3
1.6
0.34
0.33
mg/l
0.06
27
183
16
111
1.45
0.66
1.3
1.7
85.38
109.19
ng/l
0.93
16
111
25
325
0.77
0.63
3.1
4.0
26.44
40.69
u/ml
0.93
25
318
46
380
1.22
0.61
2.0
2.4
230.69
77.34
ug/min
0.43
24
223
25
192
1.31
0.59
1.9
1.4
—
—
—
0
0
25
192
1.31
0.59
1.2
1.3
287.07
213.26
miu/ml
—
6
69
26
201
1.30
0.59
1.2
1.2
281.05
274.25
mosm/kgh2o
0.72
20
145
0
23
0.00
0.58
0.0
1.4
—
8.03
—
0
23
6
35
1.72
0.57
2.0
2.5
—
—
—
0
0
6
37
1.62
0.55
2.0
2.4
—
—
—
0
0
6
40
1.50
0.51
1.0
1.3
24.17
11.87
mm/h
—
6
40
32
260
1.24
0.51
1.4
1.4
1302.15
4923.86
e6/l
0.55
26
182
47
550
0.85
0.49
1.6
1.8
3.12
3.48
mmol/l
0.94
28
408
7
45
1.56
0.49
1.9
2.2
0.61
0.60
mmol/l
—
7
45
19
145
1.31
0.49
1.5
2.2
0.50
1.43
u/field
—
10
68
28
226
1.24
0.48
1.4
1.4
4567.06
90108.72
e6/l
1.89
17
127
7
47
1.49
0.47
7.0
2.0
17.50
18.69
ug/l
—
7
39
12
85
1.41
0.47
2.1
3.8
0.92
1.25
%
0.64
12
85
23
183
1.26
0.45
3.4
2.8
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
28.82
—
0
16
14
105
1.34
0.41
2.4
2.5
—
—
—
0
0
8
59
1.36
0.41
1.1
1.3
25.75
30.30
umol/l
—
8
54
27
224
1.21
0.38
1.3
1.1
—
—
—
0
0
8
113
0.71
0.37
1.1
1.2
—
—
—
0
0
70
771
0.90
0.33
1.7
2.0
3.04
3.41
ratio
2.49
51
628
35
305
1.15
0.31
1.1
1.2
28.34
43.03
u/l
0.86
30
261
7
56
1.25
0.29
2.4
3.1
11.86
10.12
kpa
—
7
56
7
56
1.25
0.29
2.4
3.1
4.65
4.84
kpa
—
7
56
16
190
0.84
0.23
1.1
1.2
1.38
1.58
g/l
2.81
16
190
5
39
1.28
0.23
1.0
1.2
1.18
0.91
mg/l
—
5
28
0
11
0.00
0.21
0.0
1.6
—
6.17
—
0
6
0
10
0.00
0.21
0.0
1.9
—
25.60
—
0
10
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
7
59
1.19
0.18
1.3
1.3
—
—
—
0
0
5
68
0.73
0.17
1.8
1.2
79.00
384.85
u/l
—
5
62
12
101
1.19
0.16
5.6
1.8
—
—
—
0
0
180
1766
1.02
0.08
1.5
1.4
—
—
—
0
0
5
60
0.83
0.08
1.4
1.1
—
—
—
0
0
7
64
1.09
0.08
5.7
2.8
13.71
13.28
%
—
7
64
7
83
0.84
0.07
1.3
1.7
77.14
87.93
umol/l
—
7
83
38
369
1.03
0.03
2.6
1.7
8.51
5.63
mg/l
0.42
29
295
25
260
0.96
0.03
1.4
1.5
—
—
—
0
0
19
192
0.99
0.00
2.8
5.1
276.62
349.46
umol/l
1.25
13
170
40
397
1.01
0.00
1.2
1.2
—
—
—
0
0
29
295
0.98
0.00
1.3
1.4
0.98
0.82
nmol/l
0.60
15
240
21
210
1.00
-0.00
1.1
1.3
0.84
0.92
g/l
0.78
21
210
0
6
0.00
-0.00
0.0
1.0
—
0.01
—
0
6
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
2.83
—
0
6
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
7.61
—
0
5
7
71
0.99
-0.00
1.1
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
6.04
—
0
9
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_GIANTCELL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_GIANTCELL | 1.291 [1.17, 1.42] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.054 |
During the follow-up period (1.1.1998 — 31.12.2019), 1604 out of 4624 females with M13_GIANTCELL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_GIANTCELL | 1.32 [1.14, 1.52] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 859 out of 2239 males with M13_GIANTCELL died.
Mortality risk
Mortality risk for people of age
years, who have M13_GIANTCELL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.134% | 0.217% |
| 5 | 0.717% | 1.508% |
| 10 | 1.759% | 3.57% |
| 15 | 3.324% | 7.161% |
| 20 | 5.818% | 12.419% |
Relationships between endpoints
↥Index endpoint: M13_GIANTCELL – Giant cell arteritis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data